MAR 14, 2016 2:52 PM PDT

Defining the Role of Tumor Necrosis Factor During Chronic Viral Infections

WRITTEN BY: Kara Marker
Some viral infections, like HIV, are chronic, while others are acute. HIV infections are labeled chronic because the virus targets and kills helper T cells, and without these lymphocytes the body cannot fight off the HIV infection. Viruses causing acute infections, like the seasonal “stomach bug,” work differently and can be eliminated by the body.

New research from a collaboration between the University of Bonn, University of Cologne, and the Technical University of Munich has led to the discovery of an explanation for why certain viral infections are chronic and others are not. This same discovery has promise for generating new therapeutic targets.
 
Helper T cells secrete inflammatory messengers, a kind of “distress call” to killer T cells to come to their aid and fight off invading pathogens. However, viruses that cause a chronic infection, like HIV, employ virulence factors to silence these messages, ironically rendering the helper T cells helpless and ineffective.
 
In the recent collaborative study, published in the journal Nature Immunology, scientists studied mice models of chronic viral infection to see which helper T cell genes remain active when silenced by viruses. They were able to implicate tumor necrosis factor (TNF) as an agent of chronic viral infection. TNF controls various signaling pathways that inhibit helper T cell activity during chronic inflammation. In mice suffering from HIV-esque chronic viral infections with TNF inactivated, helper T cells produce inflammatory messengers like normal.
 
TNF plays a role in several different functions.

 
“After ten days, the animals had completely eliminated the virus; they were healthy,” explained Dr. Marc Beyer from the University of Bonn.
 
Meanwhile, during acute viral infections, TNF has the opposite effect. It boosts the immune system and stimulates apoptosis in cells corrupted by viral particles.
 
“In an acute infection, large quantities of TNF are formed very rapidly," said Dr. Zeinab Abdullah from the University of Bonn. "In chronic infections, on the other hand, the body secretes small amounts of TNF over a long period of time. This appears to cause the helper T cells to shut down to some extent."
 
The difference seems to stem from some sort of protective mechanism that prevents healthy tissues from being damaged from persistent inflammation, however the team is still in the dark about how exactly TNF works on a molecular level. For the time being, TNF inhibitors could be useful as a therapeutic treatment for patients with chronic viral infections like they are currently used for patients with rheumatoid arthritis and other autoimmune diseases.
 
 
Source: University of Bonn
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 23, 2020
Immunology
Gene That Fuels Antibody Factories Discovered
SEP 23, 2020
Gene That Fuels Antibody Factories Discovered
Antibodies are Y-shaped proteins that play a central role in the immune system’s arsenal of germ-busting weapons. ...
SEP 28, 2020
Genetics & Genomics
Why Some Young, Healthy People Get Severe COVID-19
SEP 28, 2020
Why Some Young, Healthy People Get Severe COVID-19
Since the start of the pandemic, scientists have been trying to find out why some people get such severe illness from SA ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
DEC 15, 2020
Immunology
Yes, You Should Get Your Flu Vaccine.
DEC 15, 2020
Yes, You Should Get Your Flu Vaccine.
A recent study published in Science Translational Medicine has provided fresh insights on how our immune systems protect ...
DEC 20, 2020
Microbiology
How Do mRNA Vaccines Work?
DEC 20, 2020
How Do mRNA Vaccines Work?
Scientist Katalin Karikó studied mRNA vaccines for years. She spent years getting grant rejections, but has now helped c ...
Loading Comments...